Published 3 days ago • loading... • Updated 3 days ago

Bavarian Nordic’s Jynneos highlights unmet need for mpox prevention in HIV patients, says GlobalData

Summary by GlobalData

A recent study reveals that a single dose of Bavarian Nordic’s Jynneos vaccine demonstrated 58% overall effectiveness in preventing mpox infection. Among the participants without HIV, effectiveness rose to 84%, while those with HIV showed only 35% effectiveness. These findings underscore the critical need for enhanced mpox prevention strategies for vulnerable, high-risk populations, particularly those with HIV, says GlobalData, a leading data an…

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All

Left

Center

Right

Express Pharma

Bavarian Nordic’s Jynneos highlights unmet need for mpox prevention in HIV patients: GlobalData - Express Pharma

A recent study reveals that a single dose of Bavarian Nordic’s Jynneos vaccine demonstrated 58 per cent overall effectiveness in preventing mpox infection. Among the participants without HIV, effectiveness rose to 84 per cent, while those with HIV showed only 35 per cent effectiveness. These findings underscore the critical need for enhanced mpox prevention strategies for vulnerable, high-risk populations, particularly those with HIV, says Globa…

3 days ago

Read Full Article